These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 17624531

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation.
    Lima-Júnior RC, Figueiredo AA, Freitas HC, Melo ML, Wong DV, Leite CA, Medeiros RP, Marques-Neto RD, Vale ML, Brito GA, Oriá RB, Souza MH, Cunha FQ, Ribeiro RA.
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):931-42. PubMed ID: 22101361
    [Abstract] [Full Text] [Related]

  • 3. Carvacrol reduces irinotecan-induced intestinal mucositis through inhibition of inflammation and oxidative damage via TRPA1 receptor activation.
    Alvarenga EM, Souza LK, Araújo TS, Nogueira KM, Sousa FB, Araújo AR, Martins CS, Pacífico DM, de C Brito GA, Souza EP, Sousa DP, Medeiros JV.
    Chem Biol Interact; 2016 Dec 25; 260():129-140. PubMed ID: 27838229
    [Abstract] [Full Text] [Related]

  • 4. Effects of the tumour necrosis factor-alpha inhibitors pentoxifylline and thalidomide in short-term experimental oral mucositis in hamsters.
    Lima V, Brito GA, Cunha FQ, Rebouças CG, Falcão BA, Augusto RF, Souza ML, Leitão BT, Ribeiro RA.
    Eur J Oral Sci; 2005 Jun 25; 113(3):210-7. PubMed ID: 15953245
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice.
    Wu ZQ, Han XD, Wang Y, Yuan KL, Jin ZM, Di JZ, Yan J, Pan Y, Zhang P, Huang XY, Wang ZG, Zheng Q.
    Cancer Chemother Pharmacol; 2011 Jul 25; 68(1):87-96. PubMed ID: 20844880
    [Abstract] [Full Text] [Related]

  • 11. Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.
    Soares PM, Lima-Junior RC, Mota JM, Justino PF, Brito GA, Ribeiro RA, Cunha FQ, Souza MH.
    Cancer Chemother Pharmacol; 2011 Sep 25; 68(3):713-20. PubMed ID: 21153821
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Olmesartan decreased levels of IL-1β and TNF-α, down-regulated MMP-2, MMP-9, COX-2, RANK/RANKL and up-regulated SOCs-1 in an intestinal mucositis model.
    de Araújo RF, Reinaldo MP, Brito GA, Cavalcanti Pde F, Freire MA, de Medeiros CA, de Araújo AA.
    PLoS One; 2014 Sep 25; 9(12):e114923. PubMed ID: 25531650
    [Abstract] [Full Text] [Related]

  • 15. Saireito (TJ-114), a Japanese traditional herbal medicine, reduces 5-fluorouracil-induced intestinal mucositis in mice by inhibiting cytokine-mediated apoptosis in intestinal crypt cells.
    Kato S, Hayashi S, Kitahara Y, Nagasawa K, Aono H, Shibata J, Utsumi D, Amagase K, Kadowaki M.
    PLoS One; 2015 Sep 25; 10(1):e0116213. PubMed ID: 25565296
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Side-Effects of Irinotecan (CPT-11), the Clinically Used Drug for Colon Cancer Therapy, Are Eliminated in Experimental Animals Treated with Latex Proteins from Calotropis procera (Apocynaceae).
    de Alencar NM, da Silveira Bitencourt F, de Figueiredo IS, Luz PB, Lima-Júnior RC, Aragão KS, Magalhães PJ, de Castro Brito GA, Ribeiro RA, de Freitas AP, Ramos MV.
    Phytother Res; 2017 Feb 25; 31(2):312-320. PubMed ID: 27910140
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide.
    Yang XX, Hu ZP, Chan SY, Duan W, Ho PC, Boelsterli UA, Ng KY, Chan E, Bian JS, Chen YZ, Huang M, Zhou SF.
    Curr Drug Metab; 2006 May 25; 7(4):431-55. PubMed ID: 16724931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.